Silencing TLR4/MyD88 signalling in tumour cells results in reduced tumour formation, and the inhibition of tumour-cell apoptosis by MyD88-dependent TLR4 signalling was observed in EOC [19,21]. The gene discussed is TLR4; the disease is neoplasm.